ArticleBiomedicines2026

Real-World Effectiveness and Safety of Anti-CGRP Monoclonal Antibodies in the Prevention of High-Frequency Episodic and Chronic Migraine in Romania-A Multicenter Retrospective Observational Study.

Alin Ciubotaru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.